miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222.
miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222.
复制标题
DOI:
10.1038/onc.2011.260
复制
发表时间:
2012-02-02
期刊:
影响因子:
8
通讯作者:
Croce, C. M.
中科院分区:
文献类型:
--
作者:
Acunzo, M.;Visone, R.;Romano, G.;Veronese, A.;Lovat, F.;Palmieri, D.;Bottoni, A.;Garofalo, M.;Gasparini, P.;Condorelli, G.;Chiariello, M.;Croce, C. M.
Non-small cell lung cancer (NSCLC) accounts for approximately 80% of all lung cancers. While some advances in lung cancer therapy have been made, patient survival is still quite poor. Two microRNAs, miR-221 and miR-222, up-regulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TRAIL resistance in NSCLC cell lines, through the down-regulation of p27kip1, PTEN and TIMP3. Here we further investigated this pathway and showed that miR-130a, expressed at low level in lung cancer cell lines, by targeting MET was able to reduce TRAIL resistance in NSCLC cells through the c-Jun mediated downregulation of miR-221 and miR-222. Moreover, we found that miR-130a reduced NSCLC migratory capacity. A better understanding of MET-miR-221&222 axis regulation in drug resistance is the key in developing new strategies in NSCLC therapy.
登录
查看更多内容
DOI:
10.2741/2354
发表时间:
2007-05-01
期刊:
FRONTIERS IN BIOSCIENCE
影响因子:
--
作者:
Schaefer, Uta;Voloshanenko, Oksana;Walczak, Henning
通讯作者:
Walczak, Henning
影响因子:
4.7
作者:
Sorrentino, Antonio;Liu, Chang-Gong;Ferlini, Cristiano
通讯作者:
Ferlini, Cristiano
影响因子:
50.3
作者:
Garofalo M;Di Leva G;Romano G;Nuovo G;Suh SS;Ngankeu A;Taccioli C;Pichiorri F;Alder H;Secchiero P;Gasparini P;Gonelli A;Costinean S;Acunzo M;Condorelli G;Croce CM
通讯作者:
Croce CM
影响因子:
11.5
作者:
Peruzzi, Benedetta;Bottaro, Donald P.
通讯作者:
Bottaro, Donald P.
影响因子:
32.4
作者:
Wiley, SR;Schooley, K;Goodwin, RG
通讯作者:
Goodwin, RG